Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound

Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for ...
CNBCTV18

Eli Lilly says obesity pill helps patients maintain weight loss after switch from injections

Eli Lilly’s orforglipron pill helps maintain weight loss after Zepbound or Wegovy injections, with FDA review underway. Learn ...

Wegovy maker Novo Nordisk files for FDA approval of obesity drug CagriSema

Wegovy maker Novo Nordisk filed for U.S. FDA approval of CagriSema, a once-weekly shot that combines two compounds to treat ...
Healio

Oral agent combined with Wegovy may preserve lean mass for older adults with obesity

A selective androgen receptor modulator combined with a GLP-1 may induce weight loss for older adults with obesity while ...

GLP 1s: 14 Users Discuss

For the last installment of the America in Focus project this year, we spoke with 14 Americans from all walks of life who are ...
STAT

Employers drop coverage for weight loss drugs as pharma’s direct-to-consumer programs grow

Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...
MedPage Today

I'm a Doctor Who Tried GLP-1 Drugs. Here's How They Changed My Life.

In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike," talks with Christle Guevarra, DO, MS, about her struggle with weight, her journey with GLP-1 drugs, and her career in medicine.

Ozempic is a serious drug with serious risks. Here’s what to know.

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...